Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Assembly Biosciences (ASMB) and Intersect ENT (XENT).
Assembly Biosciences (ASMB)
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Assembly Biosciences. The company’s shares closed last Monday at $14.53.
According to TipRanks.com, Prasad is a 5-star analyst with an average return of 11.2% and a 52.3% success rate. Prasad covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Alexion Pharmaceuticals, and Rocket Pharmaceuticals.
Currently, the analyst consensus on Assembly Biosciences is a Moderate Buy with an average price target of $30.00.
See today’s analyst top recommended stocks >>
Intersect ENT (XENT)
Oppenheimer analyst Suraj Kalia assigned a Hold rating to Intersect ENT today. The company’s shares closed last Monday at $15.94.
According to TipRanks.com, Kalia is a 4-star analyst with an average return of 3.0% and a 50.3% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Cardiovascular Systems.
Currently, the analyst consensus on Intersect ENT is a Hold with an average price target of $18.13, a 16.6% upside from current levels. In a report issued on October 22, Piper Sandler also maintained a Hold rating on the stock with a $16.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
